Guobang Pharma Ltd Total Liabilities

Latest as of June 2026: CN¥2.98 Billion CNY ≈ $436.31 Million USD

Guobang Pharma Ltd total liabilities. Based on the latest financial reports, Guobang Pharma Ltd (605507) has total liabilities worth CN¥2.98 Billion CNY (≈ $436.31 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Guobang Pharma Ltd's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Guobang Pharma Ltd (2017–2025)

Total liabilities of Guobang Pharma Ltd from 2017 to 2025. This chart illustrates how Guobang Pharma Ltd's total liabilities have evolved over time, based on quarterly financial data.

Guobang Pharma Ltd Competitors by Total Liabilities

The table below lists competitors of Guobang Pharma Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Wuhan Yangtze Communication Industry Group Co Ltd SHG:600345	China	CN¥1.06 Billion
Baoding Heavy Industry Co Ltd SHE:002552	China	CN¥2.99 Billion
Dime Community Bancshares, Inc. NYSE:DCOM	USA	$13.49 Billion
Greif Bros Corporation NYSE:GEF	USA	$2.57 Billion
A10 Network NYSE:ATEN	USA	$439.71 Million
Star Petroleum Refining Co Ltd BK:SPRC	Thailand	฿32.17 Billion
Sonos Inc NASDAQ:SONO	USA	$455.12 Million
Ruentex Industries Ltd TW:2915	Taiwan	NT$14.94 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Guobang Pharma Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Guobang Pharma Ltd's balance sheet.

Liquidity & Leverage Metrics

Guobang Pharma Ltd Total Liabilities Ratios Explained

Guobang Pharma Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guobang Pharma Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guobang Pharma Ltd (2017–2025)

The table below shows the annual total liabilities of Guobang Pharma Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.43 Billion ≈ $355.45 Million	-10.97%
2024-12-31	CN¥2.73 Billion ≈ $399.25 Million	-6.70%
2023-12-31	CN¥2.92 Billion ≈ $427.94 Million	+54.85%
2022-12-31	CN¥1.89 Billion ≈ $276.36 Million	+61.78%
2021-12-31	CN¥1.17 Billion ≈ $170.82 Million	-47.75%
2020-12-31	CN¥2.23 Billion ≈ $326.97 Million	+4.24%
2019-12-31	CN¥2.14 Billion ≈ $313.67 Million	+20.79%
2018-12-31	CN¥1.77 Billion ≈ $259.67 Million	-2.33%
2017-12-31	CN¥1.82 Billion ≈ $265.86 Million	--

About Guobang Pharma Ltd

SHG:605507 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.80 Billion

CN¥12.29 Billion CNY

Market Cap Rank

#6303 Global

#1215 in China

Share Price

CN¥15.71

Change (1 day)

-0.63%

52-Week Range

CN¥14.50 - CN¥29.25

All Time High

CN¥43.71